A rigorous evaluation of survival rates has shown that cancer patients with localised prostate cancer—the most common form of prostate cancer—have a better chance of survival if treated by surgery than by radiotherapy. ...
Dec 14, 2015
0
14
A diagnosis of prostate cancer can bring up many worries. There may be a general fear around having cancer, questions about the best treatment, and anxiety about how a treatment could affect such vital things as sexual function ...
Jul 7, 2022
0
23
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered that a protein produced by a cancer gene leads to the development of a deadly, late-stage form of prostate ...
Apr 1, 2016
0
6
Chubby, pink and anesthetized into unconsciousness and paralysis, 16-week-old Ian Lund was a small bump under blue drapes on an operating table at University of Chicago Medicine. Perched above him was a robot, with arms like ...
Mar 2, 2012
0
1
Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these ...
Sep 14, 2016
0
64
Loyola Medicine physicians have proposed a simple new system to improve the reporting of robotic surgeries performed by surgeons in training.
Sep 26, 2017
0
4
You may know that your surgeon is using the latest minimally invasive technology for your surgery, but how do you know if they've mastered it? To help answer that question, researchers at Keck Medicine of USC looked to a ...
Dec 11, 2017
0
0
In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found.
May 20, 2016
0
3
Prostate cancer is the most commonly diagnosed non-skin cancer in the U.S., and radical prostatectomy, the surgical removal of the prostate gland, remains the most popular therapeutic option, accounting for half of treatments.
May 16, 2012
0
0
A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators ...
Apr 6, 2023
0
7
